Postoperative Venous Thromboembolism in Colon and Rectal Cancer: Do Tumor Location and Operation Matter?

被引:7
作者
McKenna, Nicholas P. [1 ,3 ]
Bews, Katherine A. [2 ]
Behm, Kevin T. [1 ]
Habermann, Elizabeth B. [2 ]
Cima, Robert R. [1 ]
机构
[1] Mayo Clin, Div Colon & Rectal Surg, Rochester, MN USA
[2] Mayo Clin, Robert D & Patricia E Kern Ctr Sci Hlth Care Deliv, Rochester, MN USA
[3] 200 1st St SW, Rochester, MN 55905 USA
关键词
COLORECTAL-CANCER; RISK-FACTORS; LAPAROSCOPIC SURGERY; PROPHYLAXIS; THROMBOSIS; DISEASE; THROMBOPROPHYLAXIS; ENOXAPARIN; ADHERENCE; DURATION;
D O I
10.1097/XCS.0000000000000537
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Existing venous thromboembolism (VTE) risk scores help identify patients at increased risk of postoperative VTE who warrant extended prophylaxis in the first 30 days. However, these methods do not address factors unique to colorectal surgery, wherein the tumor location and operation performed vary widely. VTE risk may extend past 30 days. Therefore, we aimed to determine the roles of tumor location and operation in VTE development and evaluate VTE incidence through 90 days postoperatively.STUDY DESIGN: Adult patients undergoing surgery for colorectal cancer between January 1, 2005, and December 31, 2021, at a single institution were identified. Patients were then stratified by cancer location and by operative extent. VTEs were identified using diagnosis codes in the electronic medical record and consisted of extremity deep venous thromboses, portomesenteric venous thromboses, and pulmonary emboli.RESULTS: A total of 6,844 operations were identified (72% segmental colectomy, 22% proctectomy, 6% total (procto)colectomy), and tumor location was most commonly in the ascending colon (32%), followed by the rectum (31%), with other locations less common (sigmoid 16%, rectosigmoid junction 9%, transverse colon 7%, descending colon 5%). The cumulative incidence of any VTE was 3.1% at 90 days with a relatively steady increase across the entire 90-day interval. Extremity deep venous thromboses were the most common VTE type, accounting for 37% of events, and pulmonary emboli and portomesenteric venous thromboses made up 33% and 30% of events, respectively. More distal tumor locations and more anatomically extensive operations had higher VTE rates.CONCLUSIONS: When considering extended VTE prophylaxis after colorectal surgery, clinicians should account for the operation performed and the location of the tumor. Further study is necessary to determine the optimal length of VTE prophylaxis in high-risk individuals. (J Am Coll Surg 2023;236:658-665. (c) 2023 by the American College of Surgeons. Published by Wolters Kluwer Health, Inc. All rights reserved.)
引用
收藏
页码:658 / 665
页数:8
相关论文
共 36 条
  • [1] Elevated Venous Thromboembolism Risk Following Colectomy for IBD Is Equal to Those for Colorectal Cancer for Ninety Days After Surgery
    Ali, Fadwa
    Al-Kindi, Sadeer G.
    Blank, Jacqueline J.
    Peterson, Carrie Y.
    Ludwig, Kirk A.
    Ridolfi, Timothy J.
    [J]. DISEASES OF THE COLON & RECTUM, 2018, 61 (03) : 375 - 381
  • [2] Postoperative Portomesenteric Venous Thrombosis: Lessons Learned From 1,069 Consecutive Laparoscopic Colorectal Resections
    Allaix, Marco E.
    Krane, Mukta K.
    Zoccali, Marco
    Umanskiy, Konstantin
    Hurst, Roger
    Fichera, Alessandro
    [J]. WORLD JOURNAL OF SURGERY, 2014, 38 (04) : 976 - 984
  • [3] A Validation Study of a Retrospective Venous Thromboembolism Risk Scoring Method
    Bahl, Vinita
    Hu, Hsou Mei
    Henke, Peter K.
    Wakefield, Thomas W.
    Campbell, Darrell A., Jr.
    Caprini, Joseph A.
    [J]. ANNALS OF SURGERY, 2010, 251 (02) : 344 - 350
  • [4] Does Implementation of Enhanced Recovery after Surgery (ERAS) Protocols in Colorectal Surgery Improve Patient Outcomes?
    Ban, Kristen A.
    Berian, Julia R.
    Ko, Clifford Y.
    [J]. CLINICS IN COLON AND RECTAL SURGERY, 2019, 32 (02) : 109 - 113
  • [5] Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer
    Becattini, Cecilia
    Pace, Ugo
    Pirozzi, Felice
    Donini, Annibale
    Avruscio, Giampiero
    Rondelli, Fabio
    Boncompagni, Michela
    Chiari, Damiano
    De Prizio, Marco
    Visona, Adriana
    De Luca, Raffaele
    Guerra, Francesco
    Muratore, Andrea
    Portale, Giuseppe
    Milone, Marco
    Castagnoli, Giampaolo
    Righini, Marc
    Martellucci, Jacopo
    Persiani, Roberto
    Frasson, Stefania
    Dentali, Francesco
    Delrio, Paolo
    Campanini, Mauro
    Gussoni, Gualberto
    Vedovati, Maria Cristina
    Agnelli, Giancarlo
    [J]. BLOOD, 2022, 140 (08) : 900 - 908
  • [6] Bergqvist D, 1997, BRIT J SURG, V84, P1099
  • [7] Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer.
    Bergqvist, D
    Agnelli, G
    Cohen, AT
    Eldor, A
    Nilsson, PE
    Le Moigne-Amrani, A
    Dietrich-Neto, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) : 975 - 980
  • [8] Postoperative Venous Thromboembolism in Patients Undergoing Abdominal Surgery for IBD: A Common but Rarely Addressed Problem
    Brady, Matthew T.
    Patts, Gregory J.
    Rosen, Amy
    Kasotakis, George
    Siracuse, Jeffrey J.
    Sachs, Teviah
    Kuhnen, Angela
    Kunitake, Hiroko
    [J]. DISEASES OF THE COLON & RECTUM, 2017, 60 (01) : 61 - 67
  • [9] Timing and Perioperative Risk Factors for In-Hospital and Post-Discharge Venous Thromboembolism After Colorectal Cancer Resection
    Davenport, Daniel L.
    Vargas, H. David
    Kasten, Michael W.
    Xenos, Eleftherios S.
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2012, 18 (06) : 569 - 575
  • [10] Venous thromboembolism in colorectal surgery: Incidence, risk factors, and prophylaxis
    Emoto, Shigenobu
    Nozawa, Hiroaki
    Kawai, Kazushige
    Hata, Keisuke
    Tanaka, Toshiaki
    Shuno, Yasutaka
    Nishikawa, Takeshi
    Sasaki, Kazuhito
    Kaneko, Manabu
    Hiyoshi, Masaya
    Murono, Koji
    Ishihara, Soichiro
    [J]. ASIAN JOURNAL OF SURGERY, 2019, 42 (09) : 863 - 873